Angiotensin-converting enzyme (ACE) inhibitors were found to be independently associated with reducing all-cause mortality in ...

Real-world EHR data suggest ACE inhibitor use is independently associated with lower all-cause mortality in idiopathic pulmonary fibrosis, while no similar survival association was observed in COPD.

A new large-scale real-world study has found that the use of angiotensin-converting enzyme (ACE) inhibitors may be associated with improved survival in patients with idiopathic pulmonary fibrosis (IPF ...

Among patients with idiopathic pulmonary fibrosis, the risk for all-cause mortality was significantly lower with vs. without angiotensin-converting enzyme inhibitor use started within 5 years before ...

Dr. Butler answers the question: 'Side Effects Of ACE Inhibitors?' — -- Question: What are the benefits and side effects of ACE Inhibitors? Answer: There are a lot of benefits to ACE inhibitor ...